New Two-Drug attack on Tough-to-Treat cancers
NCT ID NCT05951608
Summary
This study is testing a combination of two investigational drugs, AK127 and AK112, in adults with advanced solid tumors that have progressed after standard treatments. The main goals are to find a safe dose and see if the combination can shrink tumors or slow their growth. It is for patients who have run out of other effective treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, 430022, China
Conditions
Explore the condition pages connected to this study.